Evidence map›Paper›PMID 22871906›Full record

ArticleAmerican journal of Alzheimer's disease and other dementias2012

Nonamnestic presentations of early-onset Alzheimer's disease.

Mario F Mendez, Albert S Lee, Simantini J. Karve, Jill S Shapira

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in American journal of Alzheimer's disease and other dementias, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03507257 (Longitudinal Early-onset Alzheimer's Disease Study Protocol), which is not on this map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03507257 active not recruitingnot on this mapstarted 2018, after this paper: background citation

Longitudinal Early-onset Alzheimer's Disease Study Protocol

TypeobservationalSponsorIndiana UniversityRan2018 to 2027Enrolled850ConditionsEarly Onset Alzheimer Disease, Alzheimer Disease, Mild Cognitive ImpairmentArmsFlortaucipir, Florbetaben, Fluorodeoxyglucose
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Rates of longitudinal change inAlzheimer's & dementia : the journal of the Alzheimer's Association · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Heterogeneity in Alzheimer's Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Review
  20. The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mario F MendezDepartment of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA. mmendez@ucla.edu
Albert S Lee
Simantini J. Karve
Jill S Shapira

Funding

UCLA ALZHEIMERS DISEASE RESEARCH CENTERP50AG016570 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GRILL, JOSHUA · 1999 to 2014
$25.9M
Multidisciplinary Study of Social Behavior and Emotion in Frontotemporal DementiaR01AG034499 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MENDEZ, MARIO F. · 2009 to 2013
$1.9M
NIA NIH HHS P50 AG016570NIA NIH HHS P50 AG-16570NIA NIH HHS R01 AG034499NIA NIH HHS R01AG034499-03
6 · The paper itself

Abstract

Early-onset Alzheimer's disease (EOAD) beginning before the age of 65 may differ from late-onset AD (LOAD) in clinical course and frequency of nonamnestic presentations. In a 10-year retrospective review, 125 patients with EOAD, diagnosed clinically and verified by functional neuroimaging, were compared with 56 patients with LOAD and further classified depending on predominant cognitive difficulty on presentation. Eighty (64%) of the patients with EOAD had a nonamnestic presentation, compared with only 7 (12.5%) of the patients with LOAD. Compared with LOAD, the patients with EOAD had a shorter duration with lower Mini-Mental State Examination scores. The neuroimaging reports among the patients with EOAD showed more hippocampal atrophy with an amnestic presentation, more left parietal changes with impaired language presentations, and more right parietal and occipital changes with impaired visuospatial presentations. These findings indicate that EOAD differs from LOAD in a more aggressive course and in having predominantly nonamnestic presentations that vary in neuropathological location.

Indexed as

Early DiagnosisAged, 80 and overAge of OnsetAlzheimer DiseaseApraxiasAtrophyCohort StudiesExtremitiesFemaleHippocampusHumansLanguage DisordersMaleMiddle AgedNeuropsychological TestsOccipital Lobe

Identifiers

PMID22871906
PMCPMC3625669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.